Opposition filed against patent issued to Max Planck Society on genetically engineered primates

Testbiotech: The publicly funded research institution should take on a role model function

Tuesday, 3 May 2016

Testbiotech has filed an opposition against Patent EP2328918 issued to the Max Planck Society, based in Munich. This patent claims genetically engineered animals, even including primates as “inventions”. Testbiotech believes the patent constitutes an unacceptable violation of ethical boundaries. In a letter to the president of the Max Planck Society, Testbiotech is now arguing that the publicly funded German research institution should take a leading role in protecting the interests of civil society, and initiate changes to the patent of its own accord.

Free Trade: Opening the door to genetic engineering in agriculture and food production

New analysis of CETA

2 May 2016 / A newly published report shows that the introduction of the free trade agreements between EU and Canada (CETA) and the US (TTIP) will almost certainly lead to lower EU standards in protection of consumers and the environment. Contrary to some public statements that have been made, both the German government and the EU Commission are aware of these consequences. The report written by Christoph Then was published by Greenpeace Germany.

1_ Papers CRISPR-Cas



Subscribe to testbiotech RSS